Cargando…

POLE Mutation Characteristics in a Chinese Cohort with Endometrial Carcinoma

OBJECTIVE: To study the characteristics of polymerase epsilon (POLE) exonuclease domain mutations in Chinese patients with endometrial carcinoma (EC). METHODS: This study analyzed data from 529 patients with EC in The Cancer Genome Atlas (TCGA) and 467 EC patients evaluated at the Shanghai First Mat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yiran, He, Qizhi, Li, Shuangdi, Wen, Xiaoli, Ye, Lei, Wang, Kai, Wan, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397563/ https://www.ncbi.nlm.nih.gov/pubmed/32801757 http://dx.doi.org/10.2147/OTT.S258642

Ejemplares similares

p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer
por: Wen, Xiaoli, et al.
Publicado: (2020)

Interpretation of somatic POLE mutations in endometrial carcinoma
por: León‐Castillo, Alicia, et al.
Publicado: (2020)

POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction
por: Li, Yiran, et al.
Publicado: (2019)

Phenotyping of immune and endometrial epithelial cells in endometrial carcinomas revealed by single-cell RNA sequencing
por: Guo, Yu-e, et al.
Publicado: (2021)

Phenotype of POLE-mutated endometrial cancer
por: Imboden, Sara, et al.
Publicado: (2019)

POLE exonuclease domain mutations in endometrial carcinoma: a case report
por: Pasciuto, Maria Paola, et al.
Publicado: (2023)

A Model to Identify Candidates for Lymph Node Dissection Among Patients With High-Risk Endometrial Endometrioid Carcinoma According to Mayo Criteria
por: Lu, Wen, et al.
Publicado: (2022)

Integrated Analysis of Microbiome and Transcriptome Data Reveals the Interplay Between Commensal Bacteria and Fibrin Degradation in Endometrial Cancer
por: Li, Chao, et al.
Publicado: (2021)

The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis
por: Jumaah, Alaa Salah, et al.
Publicado: (2022)

Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
por: Church, David N., et al.
Publicado: (2014)

Clinicopathological characteristics and prognostic value of POLE mutations in endometrial cancer: A systematic review and meta-analysis
por: He, Ya, et al.
Publicado: (2020)

The clinicopathological characteristics of POLE-mutated/ultramutated endometrial carcinoma and prognostic value of POLE status: a meta-analysis based on 49 articles incorporating 12,120 patients
por: Wu, Qing, et al.
Publicado: (2022)

Immune signatures of the POLE mutation in endometrial carcinomas: a systematic study based on TCGA data and clinical cohort validation
por: Wang, Tieyan, et al.
Publicado: (2023)

POLE proofreading mutation, immune response and prognosis in endometrial cancer
por: van Gool, Inge C., et al.
Publicado: (2015)

The frequency of POLE-mutation in endometrial carcinoma and prognostic implications: a systemic review and meta-analysis
por: Jumaah, Alaa Salah, et al.
Publicado: (2020)

Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region
por: Siraj, Abdul K., et al.
Publicado: (2019)

Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study
por: Yu, Shuangni, et al.
Publicado: (2022)

Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA
por: Chen, Guofang, et al.
Publicado: (2020)

Collagen triple helix repeat containing 1 promotes endometrial cancer cell migration by activating the focal adhesion kinase signaling pathway
por: Hu, Xiang, et al.
Publicado: (2020)

Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability
por: Haruma, Tomoko, et al.
Publicado: (2018)

A PDZ Protein MDA-9/Syntenin: As a Target for Cancer Therapy
por: Yu, Yongsheng, et al.
Publicado: (2019)

Endometrial Tumors with MSI-H and dMMR Share a Similar Tumor Immune Microenvironment
por: Song, Yunfeng, et al.
Publicado: (2021)

Knockdown of SLCO4C1 inhibits cell proliferation and metastasis in endometrial cancer through inactivating the PI3K/Akt signaling pathway
por: Hu, Xiang, et al.
Publicado: (2020)

Genomic profile of Chinese patients with endometrial carcinoma
por: Li, Jin, et al.
Publicado: (2023)

AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma
por: Li, Yiran, et al.
Publicado: (2015)

POLE/POLD1 mutation and tumor immunotherapy
por: Ma, Xiaoting, et al.
Publicado: (2022)

Correction: AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma
por: Li, Yiran, et al.
Publicado: (2020)

To Identify Adenomatous Polyposis Coli Gene Mutation as a Predictive Marker of Endometrial Cancer Immunotherapy
por: Song, Yunfeng, et al.
Publicado: (2022)

A novel somatic mutation in POLE exonuclease domain associated with ultra-mutational signature and MMR deficiency in endometrial cancer: a case report
por: Cui, Jiantao, et al.
Publicado: (2023)

Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer
por: Kim, Gilhyang, et al.
Publicado: (2021)

DICER1 regulates endometrial carcinoma invasion via histone acetylation and methylation
por: Li, Bilan, et al.
Publicado: (2017)

First description of ultramutated endometrial cancer caused by germline loss-of-function and somatic exonuclease domain mutations in POLE gene
por: Rosa, Reginaldo Cruz Alves, et al.
Publicado: (2020)

miR-107-5p promotes tumor proliferation and invasion by targeting estrogen receptor-α in endometrial carcinoma
por: Bao, Wei, et al.
Publicado: (2019)

POLE somatic mutations in advanced colorectal cancer
por: Guerra, Joana, et al.
Publicado: (2017)

Ultra‐mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns
por: Hu, Hanguang, et al.
Publicado: (2020)

Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE gene
por: Hino, Hitoshi, et al.
Publicado: (2019)

Mutation of the SRC Gene in Endometrial Carcinoma
por: Sugimura, Masaki, et al.
Publicado: (2000)

Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune response
por: Temko, Daniel, et al.
Publicado: (2018)

Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma
por: Jungen, Samuel H., et al.
Publicado: (2023)

TRIB3 suppresses proliferation and invasion and promotes apoptosis of endometrial cancer cells by regulating the AKT signaling pathway
por: Qu, Junjie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o9tr4vucp9rg9r74ugbpqpcrf4